Differential expression of CD44 and CD24 markers discriminates the epitheliod from the fibroblastoid subset in a sarcomatoid renal carcinoma cell line: evidence suggesting the existence of cancer stem cells in both subsets as studied with sorted cells-Reference-Cited by-同舟云学术

Differential expression of CD44 and CD24 markers discriminates the epitheliod from the fibroblastoid subset in a sarcomatoid renal carcinoma cell line: evidence suggesting the existence of cancer stem cells in both subsets as studied with sorted cells

Published:2017-01-21 Issue:9 Volume:8 Page:15593-15609
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Hsieh Chin-Hsuan¹²,Hsiung Shih-Chieh¹,Yeh Chi-Tai³,Yen Chih-Feng⁴⁵⁶,Chou Yah-Huei Wu²,Lei Wei-Yi⁷,Pang See-Tong¹⁵,Chuang Cheng-Keng¹⁵⁶,Liao Shuen-Kuei⁸⁹

Affiliation:

1. Division of Uro-oncology, Department of Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan

2. Department of Medical Research and Development, Chang Gung Memorial Hospital, Taoyuan, Taiwan

3. Cancer Center, Taipei Medical University-Shuang Ho Hospital, Taipei, Taiwan

4. Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Taoyuan, Taiwan

5. School of Medicine, Chang Gung University, Taoyuan, Taiwan

6. Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan

7. Department of Medical Science and College of Medicine, Tzu-Chi University, and Department of Internal Medicine, Tzu-Chji General Hospital, Hua-lien, Taiwan

8. The Ph.D. Program for Cancer Biology and Drug Discovery, Taipei Medical University, Taipei, Taiwan

9. Vectorite Biomedica Inc., Taipei, Taiwan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD44 Is a Prognostic Biomarker Correlated With Immune Infiltrates and Metastasis in Clear Cell Renal Cell Carcinoma;Anticancer Research;2023-07-26

2. The Role of MMP8 in Cancer: A Systematic Review;International Journal of Molecular Sciences;2019-09-11

3. Human epithelial ovarian cancer cells expressing CD105, CD44 and CD106 surface markers exhibit increased invasive capacity and drug resistance;Oncology Letters;2019-04-05

4. Total HLA Class I Antigen Loss with the Downregulation of Antigen-Processing Machinery Components in Two Newly Established Sarcomatoid Hepatocellular Carcinoma Cell Lines;Journal of Immunology Research;2018-12-16

5. PRDM14: A Potential Target for Cancer Therapy;Current Cancer Drug Targets;2018-11-13